1887

Abstract

Purpose. To detect the alteration of gut bacteria in children with ALL and analyse the impact of short-term-use of antibiotics on the changes caused by ALL.

Methodology. We collected faecal samples from both children with ALL and healthy children. According to their medication history with antibiotics, we classified the samples into ALL+ATBx, ALL, CON+ATBx and CON groups. Next-generation sequencing was performed to identify the gut bacteria according to the MiSeq platform. The Shannon index, Simpson index, Chao index and Ace index were used to represent the alpha diversity of gut bacteria. The beta diversity was estimated using the principles of co-ordinate analysis and non-metric multi-dimensional scaling. The taxon composition and presence of biomarkers were then determined through bioinformatics.

Results. With regard to alpha diversity, the Shannon index and Simpson index differed significantly between the ALL and CON groups, as well as the CON+ATBx and CON groups, but not the ALL+ATBx and CON+ATBx groups. With regard to beta diversity, the ALL and CON separated clearly into clusters, as did ALL+ATBx and CON+ATBx. There were differences in composition among the four groups at different taxonomy hierarchies. More bacteria showed an obvious difference between the paired groups ALL and CON than did for the paired groups ALL+ATBx and CON+ATBx. The area under the receiver operating characteristic curves for Bacteroidales and Enterococcaceae used to predict ALL were 0.735 and 0.724, respectively.

Conclusion. ALL induced structural changes of the gut microbiota, with the alpha diversity being significantly weakened by antibiotics, but not beta diversity. Bacteroidales and Enterococcaceae can be referred to as biomarkers for ALL.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000568
2017-08-31
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/9/1297.html?itemId=/content/journal/jmm/10.1099/jmm.0.000568&mimeType=html&fmt=ahah

References

  1. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. The Lancet 2013;381:1943–1955 [CrossRef]
    [Google Scholar]
  2. Yeoh AE, Tan D, Li CK, Hori H, Tse E et al. Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol 2013;14:e508-e523 [CrossRef][PubMed]
    [Google Scholar]
  3. Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: a review. Environ Health Perspect 2007;115:138–145 [CrossRef][PubMed]
    [Google Scholar]
  4. Sánchez-Cuaxospa M, Contreras-Ramos A, Pérez-Figueroa E, Medina-Sansón A, Jiménez-Hernández E et al. Low expression of Toll-like receptors in peripheral blood mononuclear cells of pediatric patients with acute lymphoblastic leukemia. Int J Oncol 2016;49:675–681 [CrossRef][PubMed]
    [Google Scholar]
  5. Hohlfeld R, Wekerle H. Multiple sclerosis and microbiota. From genome to metagenome?. Nervenarzt 2015;86:925–933 [CrossRef][PubMed]
    [Google Scholar]
  6. Kelly D, Conway S, Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 2005;26:326–333 [CrossRef][PubMed]
    [Google Scholar]
  7. Graziani F, Pujol A, Nicoletti C, Dou S, Maresca M et al. Ruminococcus gnavus E1 modulates mucin expression and intestinal glycosylation. J Appl Microbiol 2016;120:1403–1417 [CrossRef][PubMed]
    [Google Scholar]
  8. Stowell SR, Ju T, Cummings RD. Protein glycosylation in cancer. Annu Rev Pathol 2015;10:473–510 [CrossRef][PubMed]
    [Google Scholar]
  9. Rutkowski MR, Svoronos N, Perales-Puchalt A, Conejo-Garcia JR. The tumor macroenvironment: cancer-promoting networks beyond tumor beds. Adv Cancer Res 2015;128:235–262 [CrossRef][PubMed]
    [Google Scholar]
  10. Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 2013;34:39–58 [CrossRef][PubMed]
    [Google Scholar]
  11. Qin N, Yang F, Li A, Prifti E, Chen Y et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014;513:59–64 [CrossRef][PubMed]
    [Google Scholar]
  12. Vatanen T, Kostic AD, d'Hennezel E, Siljander H, Franzosa EA et al. Variation in Microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 2016;165:1551 [CrossRef][PubMed]
    [Google Scholar]
  13. Ling Z, Liu X, Jia X, Cheng Y, Luo Y et al. Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children. Sci Rep 2014;4:7485 [CrossRef][PubMed]
    [Google Scholar]
  14. Chu H, Khosravi A, Kusumawardhani IP, Kwon AH, Vasconcelos AC et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 2016;352:1116–1120 [CrossRef][PubMed]
    [Google Scholar]
  15. Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 2016;17:505–513 [CrossRef][PubMed]
    [Google Scholar]
  16. Pflug N, Kluth S, Vehreschild JJ, Bahlo J, Tacke D et al. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology 2016;5:e1150399 [CrossRef][PubMed]
    [Google Scholar]
  17. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016;14:e1002533 [CrossRef][PubMed]
    [Google Scholar]
  18. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59–65 [CrossRef][PubMed]
    [Google Scholar]
  19. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222–227 [CrossRef][PubMed]
    [Google Scholar]
  20. Viaud S, Daillère R, Boneca IG, Lepage P, Langella P et al. Gut microbiome and anticancer immune response: really hot Sh*t!. Cell Death Differ 2015;22:199–214 [CrossRef][PubMed]
    [Google Scholar]
  21. Rajagopala SV, Yooseph S, Harkins DM, Moncera KJ, Zabokrtsky KB et al. Gastrointestinal microbial populations can distinguish pediatric and adolescent acute lymphoblastic leukemia (ALL) at the time of disease diagnosis. BMC Genomics 2016;17:635 [CrossRef][PubMed]
    [Google Scholar]
  22. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009;75:7537–7541 [CrossRef][PubMed]
    [Google Scholar]
  23. Cole JR, Wang Q, Cardenas E, Fish J, Chai B et al. The ribosomal database project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009;37:D141–D145 [CrossRef][PubMed]
    [Google Scholar]
  24. Jami E, Israel A, Kotser A, Mizrahi I. Exploring the bovine rumen bacterial community from birth to adulthood. Isme J 2013;7:1069–1079 [CrossRef][PubMed]
    [Google Scholar]
  25. Jiang XT, Peng X, Deng GH, Sheng HF, Wang Y et al. Illumina sequencing of 16S rRNA tag revealed spatial variations of bacterial communities in a mangrove wetland. Microb Ecol 2013;66:96–104 [CrossRef][PubMed]
    [Google Scholar]
  26. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60 [CrossRef][PubMed]
    [Google Scholar]
  27. Su Q. Analyzing fractal property of species abundance distribution and diversity indexes. J Theor Biol 2016;392:107–112 [CrossRef][PubMed]
    [Google Scholar]
  28. Panda S, El Khader I, Casellas F, López Vivancos J, García Cors M et al. Short-term effect of antibiotics on human gut microbiota. PLoS One 2014;9:e95476 [CrossRef][PubMed]
    [Google Scholar]
  29. Mariat D, Firmesse O, Levenez F, Guimarăes V, Sokol H et al. The firmicutes/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009;9:123 [CrossRef][PubMed]
    [Google Scholar]
  30. Chiu CM, Huang WC, Weng SL, Tseng HC, Liang C et al. Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches. Biomed Res Int 2014;2014:1–10 [CrossRef][PubMed]
    [Google Scholar]
  31. Ling Z, Jin C, Xie T, Cheng Y, Li L et al. Alterations in the fecal microbiota of patients with HIV-1 infection: an observational study in a chinese population. Sci Rep 2016;6:30673 [CrossRef][PubMed]
    [Google Scholar]
  32. Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010;16:444–453 [CrossRef][PubMed]
    [Google Scholar]
  33. Zhang Y, Limaye PB, Renaud HJ, Klaassen CD. Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice. Toxicol Appl Pharmacol 2014;277:138–145 [CrossRef][PubMed]
    [Google Scholar]
  34. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut 2004;53:1–4 [CrossRef][PubMed]
    [Google Scholar]
  35. Whittaker RH. Evolution and measurement of species diversity. Taxon 1972;21:213–251 [CrossRef]
    [Google Scholar]
  36. Chua LL, Rajasuriar R, Azanan MS, Abdullah NK, Tang MS et al. Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome 2017;5:35 [CrossRef][PubMed]
    [Google Scholar]
  37. Liu C, Finegold SM, Song Y, Lawson PA. Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 2008;58:1896–1902 [CrossRef][PubMed]
    [Google Scholar]
  38. Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant 2015;21:1373–1383 [CrossRef][PubMed]
    [Google Scholar]
  39. Hsiao A, Ahmed AM, Subramanian S, Griffin NW, Drewry LL et al. Members of the human gut microbiota involved in recovery from vibrio cholerae infection. Nature 2014;515:423–426 [CrossRef][PubMed]
    [Google Scholar]
  40. Cuskin F, Lowe EC, Temple MJ, Zhu Y, Cameron E et al. Human gut bacteroidetes can utilize yeast mannan through a selfish mechanism. Nature 2015;517:165–169 [CrossRef][PubMed]
    [Google Scholar]
  41. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005;122:107–118 [CrossRef][PubMed]
    [Google Scholar]
  42. Aly AM, Adel A, El-Gendy AO, Essam TM, Aziz RK. Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog 2016;8:42 [CrossRef][PubMed]
    [Google Scholar]
  43. Dubin K, Callahan MK, Ren B, Khanin R, Viale A et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun 2016;7:10391 [CrossRef][PubMed]
    [Google Scholar]
  44. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011;6:e16393 [CrossRef][PubMed]
    [Google Scholar]
  45. Keren N, Konikoff FM, Paitan Y, Gabay G, Reshef L et al. Interactions between the intestinal microbiota and bile acids in gallstones patients. Environ Microbiol Rep 2015;7:874–880 [CrossRef][PubMed]
    [Google Scholar]
  46. Roberfroid M, Gibson GR, Hoyles L, Mccartney AL, Rastall R et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010;104:S1–S63 [CrossRef][PubMed]
    [Google Scholar]
  47. Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004;70:5810–5817 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000568
Loading
/content/journal/jmm/10.1099/jmm.0.000568
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error